SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-147220
Filing Date
2023-05-18
Accepted
2023-05-17 18:56:56
Documents
2
Group Members
RONALD E. OSMAN

Document Format Files

Seq Description Document Type Size
1 SC 13G d468128dsc13g.htm SC 13G 52282
2 EX-99.1 d468128dex991.htm EX-99.1 3293
  Complete submission text file 0001193125-23-147220.txt   57348
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Subject) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51823 | Film No.: 23933325
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1602 WEST KIMMEL P.O. BOX 939 MARION IL 62959
Business Address 1602 WEST KIMMEL P.O. BOX 939 MARION IL 62959 6189975151
Ronald E Osman Irrevocable Trust III (Filed by) CIK: 0001972372 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MO | Fiscal Year End: 1231
Type: SC 13G